Ikhambi lezinguquko lokuvimbela ukuguga

-Delile
I-Elysium ilabhorethri ekhulisa iphilisi elingasiza ekulweni nokuguga kwemvelo komzimba. Leli philisi liyisengezo esinomsoco, esaziwa ngokuthi iBasis, eliqukethe iNicotinamide Riboside, into eyake yakwazi ukwenza amagundane elebhu abe nempilo enhle.
Ukuhlolwa kwabantu kusenziwa ukuqinisekisa imiphumela eyiqiniso yalesi sithasiselo emzimbeni, kepha-ke, amaphilisi manje angathengwa e-United States, lapho asevele avunywa yi-FDA.

Intengo
Ama-capsules we-Basis, akhiqizwa yi-Elysium, athengiswa ngamabhodlela amaphilisi angama-60, akhonza ukugcina ukuxhaswa izinsuku ezingama-30. La mabhodlela angathengwa ngama- $ 50 eMelika.
Isebenza kanjani
INicotinamide Riboside yinto ethi, ngemuva kokungenisa, iguqulwe ibe yiNicotinamide ne-Adenine Dinucleotide, noma i-NAD, okungenye into enomsebenzi obalulekile wokulawula indlela amaseli asebenzisa ngayo amandla phakathi nempilo yawo.
Ngokuvamile, inani le-NAD emzimbeni womuntu liyancipha ngobudala, linciphise inani lamandla kumaseli. Ngakho-ke, ngalesi sengezo kungenzeka ukugcina amazinga wamandla ehlala njalo kumaseli, esiza ukulungisa i-DNA ngokushesha futhi abe namandla amaningi emisebenzini yansuku zonke.
Ungathatha kanjani
Kunconywa ukuthatha amaphilisi ama-2 we-Basis ekuseni, noma ngaphandle kokudla.
Yenzelwe ini
Ngokuya ngezakhiwo nemiphumela ye-Basis, amaphilisi angadala:
- Ukwenza ngcono enhlalakahleni ejwayelekile;
- Ukwanda kwekhwalithi yokulala;
- Ukulondolozwa komsebenzi wokuqonda;
- Ukwanda kwekhwalithi yokulala;
- Impilo yesikhumba ethuthukisiwe.
Lezi zimpawu zingathatha phakathi kwamasonto amane kuya kwayi-16 ukuvela ngemuva kokuqala ukusebenzisa lesi sithasiselo. Ngaphezu kwalokho, ukuthuthuka kokusebenza kweseli akuhlali kubonakala kalula ngaphandle.
Ngubani ongathatha
Ama-capsule akhonjisiwe kubantu abadala abaneminyaka engaphezu kwe-18 futhi akukho okuphikisanayo. Kodwa-ke, abesifazane abakhulelwe nabesifazane abancelisayo kufanele babonane nodokotela wabo wokubeletha ngaphambi kokuthatha lesi sengezo.